Brief: IGM Biosciences Announces Q3 2024 Financial Results And Provides Corporate Update
Nov 8 (Reuters) - IGM Biosciences Inc IGMS.O :
* IGM BIOSCIENCES ANNOUNCES THIRD QUARTER 2024 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
* IGM BIOSCIENCES INC: CASH RUNWAY EXPECTED TO FUND
OPERATIONS
INTO 2027
Source text: ID:nGNX2ZgwyJ
Further company coverage: IGMS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IGM Biosciences
See all newsU.S. STOCKS ON THE MOVE-Energy stocks, Apple, Vertex
U.S. STOCKS ON THE MOVE-Snap, Solventum, GlobalFoundries
IGM Biosciences rises on buyout deal with Concentra Biosciences
Brief: Igm Biosciences Enters Into Agreement To Be Acquired By Concentra Biosciences For $1.247 In Cash Per Share Plus A Contingent Value Right
IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary